Search

Author/Creator Dreyling, M.

11. EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY. (12th June 2019)

Authors:
Rule, S.; Barreto, W.G.; Briones, J.; Carella, A.M.; Casasnovas, O.; Pocock, C.; Wendtner, C.M.; Zaja, F.; Robson, S.; Tschopp, R.R.; Dreyling, M.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL. (17th June 2021)

Authors:
Schuster, S. J.; Dickinson, M.; Dreyling, M.; Martinez‐Lopez, J.; Kolstad, A.; Butler, J.; Ghosh, M.; Popplewell, L.; Chavez, J. C.; Bachy, E.; Kato, K.; Harigae, H.; Kersten, M. José; Andreadis, C.; Riedell, P. A.; Abdelhady, A.; Zia, A.; Morisse, M. C.; Fowler, N. H.; Thieblemont, C.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. ELARA: A PHASE 2 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH REFRACTORY/RELAPSED FOLLICULAR LYMPHOMA. (12th June 2019)

Authors:
Dickinson, M.; Popplewell, L.; Kolstad, A.; Ho, P.J.; Teshima, T.; Dreyling, M.; Schuster, S.; Thieblemont, C.; Ghosh, M.; Riedell, P.; Yateman, N.; Lehnhoff, K.; Lawniczek, T.; Pacaud, L.; Fowler, N.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY. (June 2017)

Authors:
Rule, S.; Jurczak, W.; Jerkeman, M.; Santucci Silva, R.; Rusconi, C.; Trneny, M.; Offner, F.; Caballero, D.; Joao, C.; Witzens‐Harig, M.; Hess, G.; Bence‐Bruckler, I.; Cho, S.; Thieblemont, C.; Zhou, W.; Henninger, T.; Goldberg, J.D.; Vermeulen, J.; Dreyling, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP. (12th June 2019)

Authors:
Frontzek, F.; Ziepert, M.; Nickelsen, M.; Altmann, B.; Glaß, B.; Hänel, M.; Trümper, L.; Held, G.; Bentz, M.; Borchmann, P.; Dreyling, M.; Viardot, A.; Metzner, B.; Kroschinsky, F.; Staiger, A.M.; Ott, G.; Rosenwald, A.; Löffler, M.; Lenz, G.; Schmitz, N.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. L‐MIND: MOR208 COMBINED WITH LENALIDOMIDE (LEN) IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R‐R DLBCL) – A SINGLE‐ARM PHASE II STUDY. (June 2017)

Authors:
Salles, G.; González Barca, E.; Jurczak, W.; Liberati, A.M.; Duell, J.; Nagy, Z.; Papajík, T.; Andre, M.; Kalakonda, N.; Dreyling, M.; Zinzani, P.L.; Ambarkhane, S.; Weirather, J.; Maddocks, K.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. MANTLE CELL LYMPHOMA OF MUCOSA‐ASSOCIATED LYMPHOID TISSUE: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF THE EUROPEAN MANTLE CELL LYMPHOMA NETWORK. (June 2017)

Authors:
Morello, L.; Rattotti, S.; Jerkeman, M.; van Meerten, T.; Krawczyk, K.; Moita, F.; Marino, D.; Ferrero, S.; Szymczyk, M.; Aurer, I.; El‐Galaly, T.C.; Di Rocco, A.; Carli, G.; Defrancesco, I.; Giordano, L.; Carlo‐Stella, C.; Dreyling, M.; Santoro, A.; Arcaini, L.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE. (June 2017)

Authors:
Ribrag, V.; Feugier, P.; Doorduijn, J.; Delfau‐Larue, M.; Hermine, O.; Kluin‐Nelemans, H.; Dasilva, M.; Lopez‐Hernandez, A.; Walewski, J.; Szymczyk, M.; Pott, C.; Homburg, C.; Van der Velden, V.; Gameiro, P.; Garcia‐Sanz, R.; Ladetto, M.; van Krieken, H.; Cabeçadas, J.; Rymkiewicz, G.; Klapper, W.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗